StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Saturday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens raised their price target on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
Read Our Latest Stock Analysis on Veradigm
Veradigm Trading Up 2.0 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- How to buy stock: A step-by-step guide for beginners
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
